SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Cantor Fitzgerald Maintains Overweight on MyoKardia, Lowers Price Target to $95

Cantor Fitzgerald maintains MyoKardia (NASDAQ:MYOK) with a Overweight and lowers the price target from $100 to $95.

Benzinga · -

Cantor Fitzgerald maintains MyoKardia (NASDAQ:MYOK) with a Overweight and lowers the price target from $100 to $95.